Business Standard

Saturday, December 28, 2024 | 08:28 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Concord Drugs Share Price

Know More
BSENSE

37.00-0.10 (-0.27%)

04:01 PM, 27-Dec-2024
Stock not traded

BSE : 538965

NSE :

Sector : Health care

ISIN Code : INE858L01010

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 27-Dec-2024 | 04:01 PM IST

Market Cap (₹ Cr)

37

Traded Value (₹ Cr)

0.01

Volume (Shares)

2,405

Face Value (₹)

10

52-Week High (₹)

61.50

52-Week High Date

29-Dec-2023

52-Week Low (₹)

30.59

52-Week Low Date

13-Aug-2024

All Time High (₹)

91.25

All Time High Date

07-Apr-2015

All Time Low (₹)

11.68

All Time Low Date

26-Mar-2020

Concord Drugs Ltd

Concord Drugs Limited established in 1995 is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals Dry Syrup powder) Tissue Bio-Adhesive tablets capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh Drugs Control Administration and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections Dry powder Injections and Ready-to-fill Pellets e...
Read More

Concord Drugs Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

37

EPS - TTM (₹) [C]

0.00

P/E Ratio (X) [C]

-

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [C]33.88
P/B Ratio (₹) [C]1.09

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

36.32

37.95

Week Low/High (₹)

35.52

40.00

Month Low/High (₹)

34.50

42.00

Year Low/High (₹)

30.59

62.00

All time Low/High (₹)

11.68

91.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-1.04%%0.840.96%
1 Month4.40%%-1.91-1.90%
3 Month-0.72%%-8.03-9.04%
6 Month-2.63%%-0.69-0.96%
1 Year-14.41%%9.259.97%
3 Year17.83%%37.0639.37%

Company Info

Company Information

Chairman & Managing Director : S Nagi Reddy

Independent Director : K Ramchandra Reddy

Whole Time Director & CFO : Koni Reddy

Independent Director : S. Nagavenkata Hareesh

Whole-time Director : S. Manoj Kumar Reddy

Independent Director : Summela Kasu

Company Sec. & Compli. Officer : Namratha Nagla

Registered Office: Survey No 249 Brahmanapally V, Hayathnagar M,Ranga Reddy,Telangana-501511 Ph: 91-40-24036379

Email:concorddrugsltd@gmail.com

URL:http://www.concorddrugs.in

FAQs about Concord Drugs Ltd

1. What's the Concord Drugs Ltd share price today?
Concord Drugs Ltd share price was Rs 37.00 at 04:01 PM IST on 27th Dec 2024. Concord Drugs Ltd share price was down by 0.27% from the previous closing price of Rs 37.10. Concord Drugs Ltd share price trend:

  • Last 1 Month: Concord Drugs Ltd share price moved up by 4.40% on BSE
  • Last 3 Months: Concord Drugs Ltd share price moved down by 0.72% on BSE
  • Last 12 Months: Concord Drugs Ltd share price moved down by 14.41% on BSE
  • Last 3 Years: Concord Drugs Ltd price moved up by 17.83% on BSE


2. How can I quickly analyse the performance of the Concord Drugs Ltd stock?
The performance of the Concord Drugs Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is _
  • Price to book value ratio is 1.09
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Concord Drugs Ltd stock is Rs 0.00


3. What is the market cap of Concord Drugs Ltd?
Concord Drugs Ltd has a market capitalisation of Rs 37 crore.


4. What is Concord Drugs Ltd's 52-week high/low share price?
The Concord Drugs Ltd’s 52-week high share price is Rs 61.50 and 52-week low share price is Rs 30.59.


5. Is the Concord Drugs Ltd profitable?
On a consolidated basis, Concord Drugs Ltd reported a profit of Rs 0.05 crore on a total income of Rs 11.85 crore for the quarter ended 2024. For the year ended Sep 2024, Concord Drugs Ltd had posted a profit of Rs 0.04 crore on a total income of Rs 12.37 crore.


6. Which are Concord Drugs Ltd’s peers in the Health care sector?
Concord Drugs Ltd’s top 5 peers in the Health care sector are Vista Pharma., Shree Ganesh Bio, Veerhealth Care, Concord Drugs, Phaarmasia, Guj. Inject(Ker), Bacil Pharma.


7. Who owns how much in Concord Drugs Ltd?
Key changes to the Concord Drugs Ltd shareholding are as follows:

  • Promoter holding in Concord Drugs Ltd has gone down to 54.39 per cent as of Sep 2024 from 55.41 per cent as of Dec 2023.